Parametrica Management LTD Catalent, Inc. Transaction History

Parametrica Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$100.34 - $115.69 $376,375 - $433,953	-3,751 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$101.51 - $125.27 $145,057 - $179,010	1,429 Added 61.54%	3,751 $388,000
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $199,413 - $244,645	2,322 New	2,322 $242,000
Q2 2019 Aug 13, 2019	SELL	$39.26 - $54.21 $195,357 - $269,748	-4,976 Closed	0 $0
Q1 2019 May 07, 2019	SELL	$29.84 - $43.92 $274,199 - $403,580	-9,189 Reduced 64.87%	4,976 $202,000

Q4 2018 Feb 12, 2019	BUY	$29.95 - $46.34 $424,241 - $656,406	14,165 New	14,165 $442,000

484

172M

865K

687K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.2B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.